Education Center

Managing Pancreatic Cancer: A Look at a Treatment Option and Phase 3 Study

This content is sponsored by Ipsen Biopharmaceuticals, Inc.

 

Click Here to Read Content.

This supplement to Federal Practitioner examines phase 3 study data supporting an FDA-approved treatment for metastatic pancreatic cancer.

Topics include:

  • Overall survival
  • Progression-free survival
  • Treatment safety data

Click Here to Read Content.

Next Article: